Showing results (81-90 of 723) with videos related to

Sort By:
Pageof 73
Current Opinion in Endocrinology, Diabetes, and Obesity|January 23, 2022
Hypertriglyceridemia: rationale, design and implementation of the Australian Hypertriglyceridemia RegistryJing Pang, Stephen C H Li, Dick C Chan, et al.
Biochemical and Biophysical Research Communications|June 1, 2005
NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24Michael Hunter, Dora Angelicheva, Ivailo Tournev, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 29, 2013
Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitusJing Pang, Dick C Chan, Sandra J Hamilton, et al.
Current Opinion in Lipidology|February 16, 2010
Genetic determinants of apolipoprotein B-100 kineticsTheodore W K Ng, Esther M M Ooi, Gerald F Watts, et al.
Journal of Lipid Research|August 30, 2012
Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndromeEsther M M Ooi, Theodore W K Ng, Gerald F Watts, et al.
Journal of Lipid Research|March 25, 2006
Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasmaMinh N Nguyen, Dick C Chan, Kevin P Dwyer, et al.
Current Opinion in Lipidology|March 10, 2025
Familial hypercholesterolemia in pregnancyFahad Alnouri, Frederick J Raal
Nature Reviews. Cardiology|January 25, 2020
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of careGerald F Watts, Samuel S Gidding, Pedro Mata, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2002
Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesityDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Pageof 73